1526 - 1550 of 6078 Results
Title
Year
-
OPENTitle: The Gray Area of Freezing of Gait Annotation: A Guideline and Open‐Source Practical ToolJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 8Start Page: 1099End Page: 1104Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13556Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13556Citation Count: 9
-
OPENTitle: AbstractsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29223Best OA location URL: https://rgu-repository.worktribe.com/preview/1862074/JONES%202022%20Feasibility%20and%20acceptability%20of%20PDConnect.pdfCitation Count: 37
- ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 20222022OPENTitle: ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022Journal Name: Pharmacoepidemiology and Drug SafetyPublisher: WileyVol: 31Issue #: S2Start Page: 3End Page: 628Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pds.5518Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.5518Citation Count: 7
- Atypical Parkinsonism with Pathological Dopamine Transporter Imaging in Neuronal Ceroid Lipofuscinosis Type 52022OPENTitle: Atypical Parkinsonism with Pathological Dopamine Transporter Imaging in Neuronal Ceroid Lipofuscinosis Type 5Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 8Start Page: 1116End Page: 1119Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13562Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13562Citation Count: 2
- Autonomic changes in Huntington’s disease correlate with altered central autonomic network connectivity2022OPENTitle: Autonomic changes in Huntington’s disease correlate with altered central autonomic network connectivityJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac253Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/5/fcac253/46682644/fcac253.pdfCitation Count: 11
- Concerns About the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's Disease2022OPENTitle: Concerns About the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 3Start Page: 509End Page: 511Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29210Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29210Citation Count: 3
-
OPENTitle: Early‐Onset Neurodevelopmental Movement Disorder Secondary to Novel Mutation in KCNN2Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13535Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13535Citation Count: 1
- Levodopa Responsive Dystonia Parkinsonism, Intellectual Disability, and Optic Atrophy Due to a Heterozygous Missense Variant in AFG3L22022OPENTitle: Levodopa Responsive Dystonia Parkinsonism, Intellectual Disability, and Optic Atrophy Due to a Heterozygous Missense Variant in AFG3L2Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13538Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13538Citation Count: 3
-
OPENTitle: Neurofilament light as a biomarker for motor decline in Parkinson’s diseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.959261Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.959261/pdfCitation Count: 21
- Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease2022OPENTitle: Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2272End Page: 2283Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29193Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804871Citation Count: 21
-
OPENTitle: Neuronal hyperactivity–induced oxidant stress promotes in vivo α-synuclein brain spreadingJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 35Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.abn0356Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.abn0356?download=trueCitation Count: 25
-
OPENTitle: “Stretched Slinky” SignJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 12Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000200075Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647796Citation Count: 3
- Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson’s disease phenotypes2022OPENTitle: Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson’s disease phenotypesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00373-0Best OA location URL: https://www.nature.com/articles/s41531-022-00373-0.pdfCitation Count: 13
- Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity2022OPENTitle: Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicityJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 9Start Page: 1134End Page: 1148Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41593-022-01140-3Best OA location URL: https://www.nature.com/articles/s41593-022-01140-3.pdfCitation Count: 152
- PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain2022OPENTitle: PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domainJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 479Issue #: 18Start Page: 1941End Page: 1965Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bcj20220308Best OA location URL: https://portlandpress.com/biochemj/article-pdf/479/18/1941/937618/bcj-2022-0308.pdfCitation Count: 7
- Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning2022OPENTitle: Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine LearningJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 12Start Page: 2376End Page: 2385Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29205Citation Count: 10
- Longitudinal corpus callosum microstructural decline in early-stage Parkinson’s disease in association with akinetic-rigid symptom severity2022OPENTitle: Longitudinal corpus callosum microstructural decline in early-stage Parkinson’s disease in association with akinetic-rigid symptom severityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00372-1Best OA location URL: https://www.nature.com/articles/s41531-022-00372-1.pdfCitation Count: 12
-
OPENTitle: Neuropathologic validation of the Alzheimer’s QuestionnaireJournal Name: Aging Clinical and Experimental ResearchPublisher: Springer Science and Business Media LLCVol: 34Issue #: 11Start Page: 2905End Page: 2909Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s40520-022-02222-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165893Citation Count: 0
- Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism2022OPENTitle: Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2217End Page: 2225Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29197Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669136Citation Count: 16
- Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?2022OPENTitle: Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2310End Page: 2312Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29202Best OA location URL: https://pure.eur.nl/files/67091036/Movement_Disorders_2022_Leys_Family_History_for_Neurodegeneration_in_Multiple_System_Atrophy_Does_it_Indicate.pdfCitation Count: 4
-
OPENTitle: Leveraging Patient Preference Information in Medical Device Clinical Trial DesignJournal Name: Therapeutic Innovation & Regulatory SciencePublisher: Springer Science and Business Media LLCVol: 57Issue #: 1Start Page: 152End Page: 159Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s43441-022-00450-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s43441-022-00450-9.pdfCitation Count: 6
- Multi-predictor modeling for predicting early Parkinson’s disease and non-motor symptoms progression2022OPENTitle: Multi-predictor modeling for predicting early Parkinson’s disease and non-motor symptoms progressionJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.977985Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.977985/pdfCitation Count: 5
- Analysis of sleep, daytime sleepiness, and autonomic function in multiple system atrophy and Parkinson disease: a prospective study2022OPENTitle: Analysis of sleep, daytime sleepiness, and autonomic function in multiple system atrophy and Parkinson disease: a prospective studyJournal Name: Journal of Clinical Sleep MedicinePublisher: American Academy of Sleep Medicine (AASM)Vol: 19Issue #: 1Start Page: 63End Page: 71Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5664/jcsm.10268Citation Count: 5
-
OPENTitle: Evaluation of Compensation Strategies for Gait Impairment in Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1212/wnl.0000000000201159Best OA location URL: https://n.neurology.org/content/neurology/99/20/e2253.full.pdfCitation Count: 14
- Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients2022OPENTitle: Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized PatientsJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 17Start Page: 9639End Page: 9639Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms23179639Best OA location URL: https://www.mdpi.com/1422-0067/23/17/9639/pdf?version=1662114737Citation Count: 18